Correlation Between Gilead Sciences and Akebia Ther

Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Akebia Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Akebia Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Gilead Sciences and Akebia Ther, you can compare the effects of market volatilities on Gilead Sciences and Akebia Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Akebia Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Akebia Ther.

Diversification Opportunities for Gilead Sciences and Akebia Ther

0.07

Correlation Coefficient

Gilead Sciences  Akebia Ther

Significant diversification

The 3 months correlation between Gilead and Akebia is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Akebia Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Ther and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Akebia Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Ther has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Akebia Ther go up and down completely randomly.

Pair Corralation between Gilead Sciences and Akebia Ther

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.46 times more return on investment than Akebia Ther. However, Gilead Sciences is 2.16 times less risky than Akebia Ther. It trades about 0.22 of its potential returns per unit of risk. Akebia Ther is currently generating about -0.05 per unit of risk. If you would invest  9,181  in Gilead Sciences on November 29, 2024 and sell it today you would earn a total of  2,059  from holding Gilead Sciences or generate 22.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.33%
Values	Daily Returns

Gilead Sciences  vs.  Akebia Ther

Gilead Sciences

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

Akebia Ther

Risk-Adjusted Performance

Very Weak

Over the last 90 days Akebia Ther has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Gilead Sciences and Akebia Ther

The main advantage of trading using opposite Gilead Sciences and Akebia Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Akebia Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will offset losses from the drop in Akebia Ther's long position.

The idea behind Gilead Sciences and Akebia Ther pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.